Utilisation of Medicare-funded schemes for people with cardiovascular disease

Julie Redfern1, Karice Hyun1, Emily Atkins1

  • 1The George Institute for Global Health, UNSW Sydney, NSW 2052, Australia.

Insights

Only 32% of cardiovascular disease (CVD) patients received a General Practice Management Plan (GPMP). Factors like diabetes and more frequent GP visits increased GPMP likelihood, highlighting potential for improved chronic disease management.

Area of Science:

  • General Practice
  • Cardiovascular Disease Management
  • Health Services Research

Background:

  • Cardiovascular disease (CVD) is a leading cause of morbidity and mortality.
  • Effective management of chronic conditions like CVD in primary care is crucial.
  • Medicare Benefit Scheme items, such as General Practice Management Plans (GPMPs), aim to support chronic disease care.

Purpose of the Study:

  • To investigate the utilization of Medicare Benefit Scheme items for chronic disease management in cardiovascular disease (CVD) patients within general practice.
  • To compare the characteristics of CVD patients who received a General Practice Management Plan (GPMP) versus those who did not.

Main Methods:

  • Subgroup analysis of baseline data from the Treatment of Cardiovascular Risk using Electronic Decision Support (TORPEDO) cohort.
  • Inclusion of 6123 patients with a diagnosis of CVD.
  • Extraction of data on demographics, diagnoses, and general practice visit frequency.

Main Results:

  • 32% (1955/6123) of CVD patients received a GPMP in the 12 months prior to data extraction.
  • Factors associated with higher GPMP utilization included younger age, diabetes diagnosis, BMI > 30 kg/m², prescription of blood pressure-lowering therapy, and >10 GP visits.
  • Only 1% of patients received a Mental Health Plan.

Conclusions:

  • Current utilization of GPMPs for CVD management in general practice is suboptimal.
  • Identifying patient and visit characteristics associated with GPMP uptake can inform targeted interventions.
  • Enhancing the utilization of existing schemes could improve systematic follow-up and support for CVD patients.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
520
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
325
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.4K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
400
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
419
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
649